Healthcare Business Div.

We provide comprehensive coordination of the pharmaceutical logistics business by utilizing our many years of experience and accumulated know-how in the pharmaceutical trade and our global network.

According to the customer’s requirements, we select the most suitable company from our domestic and overseas business partners and provide total coordination of the business of export, import, import agency, and domestic sales of pharmaceutical raw materials, APIs, and intermediates. We constantly provide the latest market information, not only through our own information network, but also by utilizing the overseas networks and assets of Mitsui Group. We focus on building new business by responding quickly and finely to the needs of each customer.

We support the domestic and overseas development of STEBORONINE for infusion, a cancer treatment/BNCT formulation developed by Japanese pharmaceutical manufacturer STELLA PHARMA CORPORATION, received approval for drug manufacturing and marketing by PMDA in May 2020, and listed it on the National Health Insurance (NHI) Drug Price List. Through the network of Mitsui Group, we conduct negotiations with domestic and overseas medical institutions and pharmaceutical companies, and provide logistics support from Japan to the local market as well.